Anesthetic management for implantation of a treatment device: The rheos baroreflex hypertensive therapy system

AANA Journal

Volumn 80, Issue 1, 2012, Pages 18-24

  Thai, Nina N ^a,b  

^a Carlsbad Medical Center   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Baroreflex; Hypertension; Hypertensive therapy; Resistant; Rheos baroreflex hypertensive therapy system

Indexed keywords

ANTIHYPERTENSIVE AGENT; REMIFENTANIL;

ADULT; AFRICAN AMERICAN; ANESTHESIA; ARTICLE; CAROTID SINUS; CASE REPORT; DEVICES; ELECTROCARDIOGRAPHY; ELECTRODE; FEMALE; HUMAN; HYPERTENSION; IMPLANTATION; LARYNGOSCOPY; PRESSORECEPTOR REFLEX; PULSE OXIMETRY; RHEOS BAROREFLEX HYPERTENSION THERAPY SYSTEM; DRUG EFFECT; ELECTROSTIMULATION THERAPY; INHALATION ANESTHESIA; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; NURSE ANESTHETIST; PHYSIOLOGY;

ANESTHESIA, INHALATION; BAROREFLEX; CAROTID SINUS; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; NURSE ANESTHETISTS; PROSTHESIS IMPLANTATION;

EID: 84860238578     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Scheffers IJ, Kroon AA, Tordoir JH, de Leeuw PW. Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension. Expert Rev Med Devices. 2008;5(1):33-39.
2. CVRx Rheos Baroreflex Hypertension Therapy System Pivotal Trial [patient information booklet]. Minneapolis, MN: CVRx, Inc; 2009.
3. Illig KA, Levy M, Sanchez L, et al. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg. 2006;44(6):1213-1218.
4. Orosco M, Sedra A. Rheos Baroreflex Hypertension System Therapy: a case report. Los Angeles, CA: University of Southern California. Unpublished.
5. Nagasaki G, Tanaka M, Nishikawa T. The recovery profile of baroreflex control of heart rate after isoflurane or sevoflurane anesthesia in humans. Anesth Analg. 2001;93(5):1127-1131.
6. Anesthetic Manual for Rheos Implantation: Synopsis of the Anesthesia Management for the Rheos System Implantation. Minneapolis, MN: CVRx, Inc. Revised January 2, 2009.
7. Tordoir JH, Scheffers I, Schmidli J, et al. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg. 2007;33(4):414-421.
8. Omoigui S. Sota Omoigui's Anesthesia Drugs Handbook. 3rd ed. Hawthorne, CA: S.O.T.A. Technologies Inc; 2004:383-387.
9. Barash PG, Cullen BF, Stoelting RK. Clinical Anesthesia. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005;342, 684, 1240-1241, 1397-1398.
10. Reves JG, Glass PS, Lubarsky DA, McEvoy MD, Martinez-Ruiz R. Intravenous anesthetics. In: Miller R, Eriksson L, Fleisher E, Weiner-Kronish JP, Young W, eds. Miller's Anesthesia. 7th ed. Vol 2. Philadelphia, PA: Churchill Livingstone Elsevier; 2010:719-768.
11. Morgan GE Jr, Mikhail MS, Murray MJ. Clinical Anesthesiology. 4th ed. New York, NY:McGraw-Hill Medical; 2002: 145, 1005-1008.
12. Filippone JD, Bisognano JD. Baroreflex stimulation in the treatment of hypertension. Curr Opin Nephrol Hypertens. 2007;16(5):403-408.
13. Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55(3):619-626.
14. Sanchez LA, Illig K, Levy M, et al. Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology. Ann Vasc Surg. 2010;24(2):178-184.